Nishadil
Signup Signin
Delhi | 25°C (windy)
The FDA's Bold New Vision: Could One Clinical Trial Be Enough for Drug Approval?

The FDA's Bold New Vision: Could One Clinical Trial Be Enough for Drug Approval?
Biomea Fusion's Latest Chapter: Unpacking the Nuances of a Pivotal Quarter

Biomea Fusion's Latest Chapter: Unpacking the Nuances of a Pivotal Quarter
A CRISPR Conundrum: Intellia's Trial Halt Jolts the Biotech World

A CRISPR Conundrum: Intellia's Trial Halt Jolts the Biotech World
Alto Neuroscience's Breakthrough: Schizophrenia Drug ALTO-301 Rockets Towards Approval with FDA Fast Track!

Alto Neuroscience's Breakthrough: Schizophrenia Drug ALTO-301 Rockets Towards Approval with FDA Fast Track!
Life-Changing Breakthrough: Cystic Fibrosis Drug Earns Developers Prestigious "American Nobel" for Decades of Extended Life

Life-Changing Breakthrough: Cystic Fibrosis Drug Earns Developers Prestigious "American Nobel" for Decades of Extended Life
Cambrex Revolutionizes Peptide Manufacturing with Major Waltham Expansion

Cambrex Revolutionizes Peptide Manufacturing with Major Waltham Expansion
Load more..